Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

deCODE and Merck & Co. form obesity alliance

Oct. 2, 2002

NO-1886 combined with exercise may prevent development of atherosclerosis in the elderly

Oct. 2, 2002

Novel calcium receptor modulators and their use described in Aventis patent

Oct. 2, 2002

Novartis designs new DPP-IV inhibitors for diabetes mellitus

Oct. 1, 2002

Thrombopoietin agonists prepared and tested at Shionogi

Oct. 1, 2002

Cholestagel MAA filed for primary hypercholesterolemia

Oct. 1, 2002

Theratechnologies adds GLP-1 program to portfolio, signs development agreement with Alza

Oct. 1, 2002

Amgen files sBLA for Enbrel for improvement of physical function in RA

Oct. 1, 2002

BMS identifies 5-HT2 receptor modulators for obesity and other disorders

Sep. 30, 2002

Biaryl LDL receptor upregulators reported in Takeda patent

Sep. 30, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...